United Therapeutics

United Therapeutics invests heavily in regenerative medicine including 3D-printed lungs and kidney xenotransplantation programs. It brings substantial manufacturing and regulatory experience. Compared with Trestle, its broader organ portfolio and larger scale may accelerate certain technologies but also dilutes singular focus on kidney tissue implants.